CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Virtual Reality Behavioral Activation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04268316
NCT04268316N/ACompleted

Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder

Stanford University·interventional·Posted Feb 13, 2020·Updated Jun 2, 2021

In Brief

A clinical study evaluating Virtual Reality Behavioral Activation and Behavioral Activation in real-life for Major Depressive Disorder and 2 related conditions. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The primary purpose of this study is to test the safety and feasibility of virtual reality (VR) technology in the use of behavioral activation (BA) as a treatment for major depressive disorder (MDD). The secondary purpose of this study is to examine whether any evidence of clinical efficacy exists for VR delivered BA.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedFeb 13, 2020
Enrollment StartMay 18, 2020
Primary CompletionJan 15, 2021
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 6.4 years ago

Interventions

Virtual Reality Behavioral Activationdevice

Participants will choose four "activities" to complete in virtual reality over the course of the week. These activities are video 360 and range from viewing animals, to viewing nature scenes, to traveling to a different location in the world, to viewing adrenaline-pumping activities.

Behavioral Activation in real-lifebehavioral

Participants will choose four pleasurable and/or mastery activities to complete over the course of the week in real life.